VeriMomIst naringenin in der Schwangerschaft sicher?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
Pregnancy-safe products containing naringenin
Related ingredients
Frequently asked questions
- Ist naringenin in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
- Ist naringenin während des Stillens sicher?
- Same rationale as for pregnancy: no harmonised reproductive classification and no authoritative CIR/SCCS contraindication identified. Potential for low systemic absorption after topical use implies low measurable exposure in breastfeeding parent (e=1). No specific data on milk transfer were found in the authoritative sources consulted.
- Ist naringenin sicher für Babyhaut?
- No infant‑specific developmental toxicity or dermal‑toxicity data indicating increased hazard. Following the specified instruction to increase exposure for infants when adult topical absorption is measurable, baby exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher permeability and greater surface‑area‑to‑weight ratio. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- Wie bewertet VeriMom naringenin?
- VeriMom bewertet naringenin mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu naringenin?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu naringenin basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.